361.1 Downregulation of Mettl14-mediated m6A modification prevents allograft survival by elevating the stabilization of Sema4D mRNA and disrupting the function of regulatory T cells
Dr. Gaoping Zhao, People's Republic of China
361.2 MHC class II sharing promotes donor treg-mediated tolerance after intestinal transplantation in swine
Dr. Muhammed Esad Gunes, United States
361.3 Revised Siplizumab-based conditioning regimen for combined kidney and bone marrow transplantation improved mixed hematopoietic chimerism with significant enrichment of regulatory T cells
Dr. Ryo Otsuka, United States
361.4 Mitigating alloimmune rejection using Circular RNA AEBP2-silenced DC in heart transplantation: A new target for tolerogenic DCs
Dr. Xiufen Zheng, Canada
361.5 Generation of CD141+CD163+ regulatory dendritic cells from live donor liver transplant perfusate
Dr. Rosalia Busà, Italy
361.6 Activation of human CD4+CD25+CD127lo Treg with alloantigen and rIL-2 induces IFNGR
Miss Ranje Al-Atiyah, Australia
361.7 Targeting the epigenetic reader BRD4 promotes transplant tolerance by inhibiting inflammatory macrophages
Dr. Xian C Li, United States
361.8 Successful mixed hematopoietic chimerism by Bcl-2 Inhibition and rapamycin encapsulating nanoparticles (ImmTOR) without chemotherapy or total body irradiation in nonhuman primates
Tatsuo Kawai, United States
361.9 Liver transplantation with delayed donor bone marrow transplantation in non-human primates achieves hematopoietic chimerism.